Metabolomic biosignature differentiates melancholic depressive patients from healthy controls

BACKGROUND: Major depressive disorder (MDD) is a heterogeneous disease at the level of clinical symptoms, and this heterogeneity is likely reflected at the level of biology. Two clinical subtypes within MDD that have garnered interest are “melancholic depression” and “anxious depression”. Metabolomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yashu, Yieh, Lynn, Yang, Tao, Drinkenburg, Wilhelmus, Peeters, Pieter, Steckler, Thomas, Narayan, Vaibhav A., Wittenberg, Gayle, Ye, Jieping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994306/
https://www.ncbi.nlm.nih.gov/pubmed/27549765
http://dx.doi.org/10.1186/s12864-016-2953-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994306/
https://www.ncbi.nlm.nih.gov/pubmed/27549765
http://dx.doi.org/10.1186/s12864-016-2953-2

Ejemplares similares